The recent second wave that has ravaged India is not likely to affect the supply of Covid19 vaccines from the country, according to Philippine ambassador to India, Ramon Bagatsing, Jr.
Bharat Biotech, the India vaccine-maker, promised to deliver 8 million doses of their jab, Covaxin by the end of the month.
Bagatsing stressed the importance of handling all the regulatory requirements in the Philippines to ensure smooth sailing. Among these requirements is the emergency use authorization, which the Philippine Food and Drug Administration has issued for the Indian vaccine.
He added that once these have been ironed out, he will need to ask permission from the Indian government to export these jabs.
The ambassador also said that the South Asian nation has not stopped producing and exporting vaccines.
“They have enough for their people so the vaccination is not an issue,” he said. “They have vaccinated over 155 million people, about 10% of their population.”
Apart from Covaxin, the Philippines is slated to buy 30 million doses of Covavax jabs from India’s Serum Institute and the US pharmaceutical firm, Novavax. These shots are expected to be delivered by September this year.
Meanwhile, 15,000 doses of the Russian vaccine, Sputnik V, finally arrived early this week, produced by Gamaleya Research Institute of Epidemiology and Microbiology.
According to National Task Force chief implementer Carlito Galvez, these will be rolled out in Taguig, Manila, Muntinlupa, Makati and Paranaque, with each city receiving an initial 3,000 doses. The additional 485,000 doses will be delivered later this month.
The vaccination of the general public is eyed to begin in August as deliveries from various pharmaceutical companies begin to arrive.